AMGN

AMGEN Inc

Feb 27 • 04:00PM ET

387.96

+8.63 2.28 %

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD IVV SPY DIA VTV XLV VIG

Index	DJIA, NDX, S&P 500	P/E	27.26	EPS (ttm)	14.23	Insider Own	0.20%	Shs Outstand	538.80M	Perf Week	3.53%
Market Cap	209.14B	Forward P/E	16.63	EPS next Y	23.33	Insider Trans	-1.09%	Shs Float	537.99M	Perf Month	13.37%
Enterprise Value	255.44B	PEG	5.06	EPS next Q	4.81	Inst Own	82.42%	Short Float	2.68%	Perf Quarter	13.73%
Income	7.71B	P/S	5.69	EPS this Y	2.56%	Inst Trans	0.94%	Short Ratio	5.04	Perf Half Y	34.72%
Sales	36.74B	P/B	24.14	EPS next Y	4.15%	ROA	8.45%	Short Interest	14.44M	Perf YTD	18.53%
Book/sh	16.07	P/C	22.91	EPS next 5Y	3.29%	ROE	106.10%	52W High	387.49 0.12%	Perf Year	26.86%
Cash/sh	16.93	P/FCF	25.82	EPS past 3/5Y	5.51% 2.93%	ROIC	12.99%	52W Low	261.43 48.40%	Perf 3Y	65.48%
Dividend Est.	10.17 (2.62%)	EV/EBITDA	16.56	Sales past 3/5Y	12.09% 7.79%	Gross Margin	70.47%	Volatility	1.86% 2.69%	Perf 5Y	72.49%
Dividend TTM	9.66 (2.49%)	EV/Sales	6.95	EPS Y/Y TTM	88.13%	Oper. Margin	27.93%	ATR (14)	8.90	Perf 10Y	162.85%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	0.90	Sales Y/Y TTM	10.56%	Profit Margin	20.99%	RSI (14)	67.07	Recom	2.41
Dividend Gr. 3/5Y	7.05% 8.27%	Current Ratio	1.14	EPS Q/Q	112.21%	SMA20	4.81%	Beta	0.46	Target Price	355.68
Payout	66.92%	Debt/Eq	6.40	Sales Q/Q	9.41%	SMA50	11.54%	Rel Volume	1.16	Prev Close	379.33
Employees	31500	LT Debt/Eq	5.86	Earnings	Feb 03 AMC	SMA200	25.26%	Avg Volume	2.87M	Price	387.96
IPO	Jun 17, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.74% 4.14%	Trades		Volume	3,314,604	Change	2.28%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-20-26	Initiated	Barclays	Equal Weight	$185
Jan-20-26	Downgrade	Bernstein	Outperform → Mkt Perform	$335
Jan-07-26	Resumed	UBS	Buy	$380
Dec-05-25	Upgrade	Erste Group	Hold → Buy
Nov-24-25	Resumed	Truist	Hold	$318
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$385
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318

Show Previous Ratings

Today 10:02AM	J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? (Zacks)
09:50AM	Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-26-26 03:42PM	Generate caps a strong month for biotech IPOs with $400M offering (BioPharma Dive)
03:40PM	Physician-Scientist Reshma Kewalramani Runs One of Biotechs Biggest Companies (Time)
10:07AM	Got $10,000? Put It in These Dividend Stocks Now (24/7 Wall St.)
08:26AM	Loading…
Feb-25-26 08:26AM	Pfizer Stock: Is PFE Underperforming the Healthcare Sector? (Barchart)
07:52AM	Is Amgen Stock Outperforming the Dow? (Barchart)
Feb-24-26 04:01PM	AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE (PR Newswire)
11:04AM	How Is Merck & Co.'s Stock Performance Compared to Other Healthcare Stocks? (Barchart)
Feb-23-26 09:40AM	Why Amgen (AMGN) is a Top Value Stock for the Long-Term (Zacks)
Feb-22-26 09:25PM	Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate (Insider Monkey)
Feb-20-26 09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:59AM	Here Are Fridays Top Wall Street Analyst Research Calls: Amgen, ETSY, Eldorado Gold, GE Aerospace, Merck, Southern Company, Walmart, Yeti, and More (24/7 Wall St.)
Feb-19-26 09:54AM	Here's What the Street is Saying About Amgen Inc. (AMGN) (Insider Monkey)
Feb-18-26 11:43PM	1 Momentum Stock to Research Further and 2 We Avoid (StockStory)
07:38PM	Loading…
07:38PM	Amgen Details Oncology R&D Push, IMDELLTRA Expansion and LUMAKRAS Updates at Citi Summit (MarketBeat)
Feb-17-26 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
Feb-13-26 10:02PM	InflaRx Spotlights Izicopan HS Data, Phase 2b Plans and 30% Cost Cuts at Guggenheim Summit (MarketBeat)
04:01PM	AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT (PR Newswire)
09:57AM	Here's What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) (Insider Monkey)
05:59AM	Amgen receives EC approval for Uplizna in generalised myasthenia gravis (Pharmaceutical Business Review)
Feb-12-26 08:14PM	Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update (MarketBeat)
09:00AM	EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA FOR GENERALIZED MYASTHENIA GRAVIS (PR Newswire)
07:55AM	Upstream Bios stock drops 47% on verekitug Phase II asthma data (Clinical Trials Arena)
Feb-11-26 04:04PM	Upstream Bio Crashes After Asthma Drug Succeeds With The Wrong Dose (Investor's Business Daily)
09:50AM	Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Feb-10-26 07:55PM	Review & Preview: Consumers Show Strain (Barrons.com)
09:42AM	AZN Q4 Earnings Miss Estimates, Stock Up on Robust 2026 Growth Outlook (Zacks)
12:37AM	The 5 Most Interesting Analyst Questions From Amgen's Q4 Earnings Call (StockStory)
Feb-09-26 04:42PM	Stock Market Today: Dow Up As Oracle Soars; Cathie Wood Buys Buffett Stock Amid 145% Run (Live Coverage) (Investor's Business Daily)
02:13PM	Loading…
02:13PM	Stock Market Today: Dow Firm As Oracle Soars On This; Hims & Hers Shares Crater On Novo Move (Live Coverage) (Investor's Business Daily)
11:22AM	Nasdaq, S&P 500 hit session highs as tech rebound picks up steam (MarketWatch)
11:06AM	Stock Market Today: Dow Gains As Nvidia Jumps; Apple Lags, Energy Stock Tests Entry (Live Coverage) (Investor's Business Daily)
09:55AM	Dow Jones retreat from highs as Amazon and Apple fall (Proactive)
09:24AM	J&J Posts Innovative Medicine Growth in 2025 Amid Stelara Patent Loss (Zacks)
09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
Feb-08-26 06:22PM	Stock Futures Drift Higher Ahead of Jobs, Inflation Data (Barrons.com)
09:44AM	The Dow Surged Past 50,000. How It Got There, and Where It Goes Next. (Barrons.com)
Feb-06-26 07:55PM	Review & Preview: 50,000 Sighs of Relief (Barrons.com)
03:53PM	The Stocks That Punch Above Their Weight in the Dow (The Wall Street Journal)
01:52PM	CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder (Benzinga)
06:03AM	Stock Market Today, Feb. 6: U.S. stocks snap three day losing streak as Russell 2000 adds 2% (TheStreet)
Feb-05-26 05:03PM	Health Care Roundup: Market Talk (The Wall Street Journal)
02:23PM	RBC Lifts Amgen (AMGN) Target After Strong Q4, Cites Key Drug Momentum (Insider Monkey)
10:08AM	Zacks Investment Ideas feature highlights: Amgen, Apple and Microsoft (Zacks)
06:32AM	Generate, an AI-driven Flagship startup, pitches an IPO (BioPharma Dive)
03:40AM	Stock Market News for Feb 5, 2026 (Zacks)
03:00AM	The most valuable up-and-coming GLP-1s (Pharma Voice)
03:00AM	Big Pharmas most valuable up-and-coming GLP-1s (Pharma Voice)
Feb-04-26 06:23PM	Rotation Trade a Boon for Dow 30 Today (Zacks) +8.15%
05:06PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:57PM	Stock Market Today: Nasdaq Sinks As Tech Sell-Off Intensifies; Alphabet Beats Wall Street Forecasts (Live Coverage) (Investor's Business Daily)
04:43PM	Broader Market Falls as Chipmakers and AI Stocks Tumble (Barchart)
04:23PM	Nasdaq, S&P 500 Settle Lower on Extended Tech Rotation (Schaeffer's Research)
04:09PM	Amgen Tops Buy Zone On Positive 2026 Outlook Amid Sharpening Obesity Focus (Investor's Business Daily)
02:35PM	Amgen (AMGN) Stock Hits 52-Week Highs: Buy Signal? (Zacks)
12:21PM	Today's Market: Dow Climbs 350 Points, Nasdaq Falls 1% as Tech Stocks Struggle (GuruFocus.com)
11:51AM	Stock Market Today: Dow Rises, Nasdaq Sinks Amid Tech Sell-Off; AMD, Uber Dive (Live Coverage) (Investor's Business Daily)
11:36AM	Amgen Hits Buy Zone On Positive 2026 Outlook Amid Sharpening Obesity Focus (Investor's Business Daily)
10:19AM	AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in Focus (Zacks)
10:16AM	Stock Market Today: Dow Rises But Nasdaq Lags On Surprise Jobs Data; Eli Lilly Soars (Live Coverage) (Investor's Business Daily)
09:51AM	Analyst Report: Amgen Inc. (Morningstar Research)
09:30AM	Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook (Zacks)
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
04:51AM	Earnings roundup: Amgen vs. FDA, Pfizers defense and Mercks $70B-in-sales plan (BioPharma Dive)
12:32AM	AMGN Q4 Deep Dive: Product Portfolio Expansion and Pipeline Progress Drive Outlook (StockStory)
12:03AM	Amgen Inc (AMGN) Q4 2025 Earnings Call Highlights: Blockbuster Growth and Strategic Challenges (GuruFocus.com)
Feb-03-26 06:10PM	Amgen (AMGN) Q4 2025 Earnings Call Transcript (Motley Fool)
06:07PM	Amgen Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Here's What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings (Zacks)
05:47PM	Markets Rotate Back Out of Tech, Q4 Earnings After the Close (Zacks)
05:10PM	Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:07PM	Amgen Eyes Buy Zone After Fourth-Quarter Beat As Obesity Studies Mount (Investor's Business Daily)
04:58PM	Amgens Revenue Climbs on Double-Digit Volume Boost (The Wall Street Journal)
04:58PM	Amgen Logs Higher Fourth-Quarter Revenue on Double-Digit Volume Boost (The Wall Street Journal)
04:41PM	Amgen beats Q4 expectations with 9% revenue growth, issues strong 2026 guidance (Investing.com)
04:13PM	Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025 (StockStory)
04:07PM	Amgen: Q4 Earnings Snapshot (Associated Press Finance)
04:04PM	Amgen quarterly results beat Street estimates on higher sales, lower tax rate (Reuters)
04:01PM	AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS (PR Newswire)
11:18AM	Silver Economy Boom: Investing in Healthcare's Aging Tailwinds (Zacks)
11:00AM	Market Awaits JOLTS Jobs Report (Zacks)
10:26AM	Q4 Earnings, JOLTS & a Changing of the Disney Guard (Zacks)
07:24AM	Jim Cramer on Amgen: "The Biotech Really Impressed Me With a Very Strong Pipeline" (Insider Monkey)
06:26AM	Nasdaq Futures Climb on Blowout Palantir Results (Barchart)
05:00AM	Advanced Micro Devices heads earnings slate (MarketWatch)
04:19AM	Stock Market Today: S&P 500 eyes fresh record as Dow and Nasdaq also called higher; Palantir rises after earnings; gold and silver rebound; AMD results on tap. (MarketWatch)
Feb-02-26 07:00PM	AMD earnings, Netflix-Warner Bros. hearing: What to Watch (Yahoo Finance Video)
09:00AM	Amgen Stock: Is Wall Street Bullish or Bearish? (Barchart)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
06:59AM	Amgen hands back eczema drug to Kyowa Kirin despite positive late-stage data (Pharmaceutical Technology)
Feb-01-26 10:11PM	Amgen (AMGN) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 08:21AM	Kyowa Kirin to regain control of rocatinlimab development, commercialization (TipRanks)
Jan-30-26 01:09PM	Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends (Benzinga)
11:15AM	Dow Jones Leader Amgen Leads These Biotech Stocks Heading Into Q4 Earnings Season (Investor's Business Daily)
06:57AM	Amgen gives up on its once-prized eczema drug (BioPharma Dive)
Jan-29-26 12:24PM	UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves (Insider Monkey)
09:40AM	Amgen (AMGN) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
09:15AM	Countdown to Amgen (AMGN) Q4 Earnings: Wall Street Forecasts for Key Metrics (Zacks)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Santos Esteban	Associate	Feb 26 '26	Proposed Sale	379.12	54,792	20,772,598		Feb 27 12:20 PM
Busch Matthew C.	VP, Finance & CAO	Feb 19 '26	Sale	375.79	1,000	375,790	3,423	Feb 20 07:43 PM
Busch Matthew C.	ASSOCIATED TO AFFILIATE	Feb 19 '26	Proposed Sale	375.00	1,000	375,000		Feb 19 03:55 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Option Exercise	169.70	3,139	532,691	8,864	Nov 21 08:34 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Sale	337.26	3,139	1,058,667	7,225	Nov 21 08:34 PM
Grygiel Nancy A.	Officer	Nov 20 '25	Proposed Sale	337.26	3,139	1,058,667		Nov 20 04:45 PM
Khosla Rachna	SVP, Business Development	Nov 12 '25	Sale	336.24	890	299,256	7,082	Nov 13 07:29 PM
Gordon Murdo	EVP, Global Commercial Ops	Nov 12 '25	Sale	336.83	6,879	2,317,071	41,923	Nov 13 07:28 PM
Gordon Murdo	Officer	Nov 12 '25	Proposed Sale	337.23	6,879	2,319,805		Nov 12 03:02 PM
Khosla Rachna	Officer	Nov 12 '25	Proposed Sale	337.42	890	300,304		Nov 12 02:50 PM
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM
Khosla Rachna	SVP, Business Development	Jun 05 '25	Sale	289.68	1,500	434,520	8,162	Jun 06 07:49 PM
Khosla Rachna	Officer	Jun 05 '25	Proposed Sale	290.00	1,500	435,000		Jun 05 12:24 PM
Busch Matthew C.	VP, Finance & CAO	May 02 '25	Sale	279.69	1,000	279,690	4,034	May 06 08:07 PM
Busch Matthew C.	Officer	May 02 '25	Proposed Sale	281.44	1,000	281,440		May 02 02:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience